Jake Bauer - 11 Aug 2025 Form 3 Insider Report for BridgeBio Oncology Therapeutics, Inc. (HLXB)

Role
Director
Signature
/s/ Aaron Chan, Attorney-in-Fact
Issuer symbol
HLXB
Transactions as of
11 Aug 2025
Net transactions value
$0
Form type
3
Filing time
18 Aug 2025, 17:14:44 UTC
Previous filing
05 May 2025
Next filing
28 Aug 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bauer Jake Director BRIDGEBIO ONCOLOGY THERAPEUTICS, INC., 256 EAST GRAND AVENUE, SUITE 104, SOUTH SAN FRANCISCO /s/ Aaron Chan, Attorney-in-Fact 18 Aug 2025 0001654909

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney